Search research articles
Contact Us
Filters
Showing results (1001-1010 of 1,457) with videos related to
Page
of 146
Sort By:
Journal of Neuro-Oncology
|
April 30, 2014
Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing
Betty Y S Kim, Wen Jiang, Jason Beiko, et al.
Journal of Neuro-Oncology
|
April 29, 2020
Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma
Dominic Maggio, Winson S Ho, Rebecca Breese, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association
|
November 30, 2022
Establishing a Clinical Protocol for Velopharyngeal MRI and Interpreting Imaging Findings
Jamie L Perry, Taylor D Snodgrass, Imani R Gilbert, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 10, 2017
The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic
Christopher R Gilbert, Rob Ely, Joelle T Fathi, et al.
The American Journal of Cardiology
|
November 1, 1986
Computer-assisted intraoperative mapping of the entire ventricular epicardium in the Wolff-Parkinson-White syndrome
H J Vidaillet, J E Lowe, L D German, et al.
Journal of Neuro-Oncology
|
July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
Mark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.
American Journal of Human Genetics
|
August 1, 1993
Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD)
J R Gilbert, J M Stajich, S Wall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2018
<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Monika E Hegi, Els Genbrugge, Thierry Gorlia, et al.
Neuro-Oncology
|
May 7, 2013
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677
Eva-Maria Ratai, Zheng Zhang, Bradley S Snyder, et al.
Molecular Vision
|
January 5, 2001
Mutations in corneal carbohydrate sulfotransferase 6 gene (CHST6) cause macular corneal dystrophy in Iceland
N P Liu, S Dew-Knight, M Rayner, et al.
Page
of 146
Search research articles
Search
Showing results (1001-1010 of 1,457) with videos related to
Sort By:
Page
of 146
Journal of Neuro-Oncology
|
April 30, 2014
Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing
Betty Y S Kim, Wen Jiang, Jason Beiko, et al.
Journal of Neuro-Oncology
|
April 29, 2020
Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma
Dominic Maggio, Winson S Ho, Rebecca Breese, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association
|
November 30, 2022
Establishing a Clinical Protocol for Velopharyngeal MRI and Interpreting Imaging Findings
Jamie L Perry, Taylor D Snodgrass, Imani R Gilbert, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 10, 2017
The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic
Christopher R Gilbert, Rob Ely, Joelle T Fathi, et al.
The American Journal of Cardiology
|
November 1, 1986
Computer-assisted intraoperative mapping of the entire ventricular epicardium in the Wolff-Parkinson-White syndrome
H J Vidaillet, J E Lowe, L D German, et al.
Journal of Neuro-Oncology
|
July 9, 2011
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
Mark R Gilbert, John Kuhn, Kathleen R Lamborn, et al.
American Journal of Human Genetics
|
August 1, 1993
Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD)
J R Gilbert, J M Stajich, S Wall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2018
<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials
Monika E Hegi, Els Genbrugge, Thierry Gorlia, et al.
Neuro-Oncology
|
May 7, 2013
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677
Eva-Maria Ratai, Zheng Zhang, Bradley S Snyder, et al.
Molecular Vision
|
January 5, 2001
Mutations in corneal carbohydrate sulfotransferase 6 gene (CHST6) cause macular corneal dystrophy in Iceland
N P Liu, S Dew-Knight, M Rayner, et al.
Page
of 146